380 related articles for article (PubMed ID: 32547515)
21. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
Fuji S; Shindo T
Stem Cell Investig; 2016; 3():70. PubMed ID: 27868052
[TBL] [Abstract][Full Text] [Related]
22. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
[TBL] [Abstract][Full Text] [Related]
23. Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches.
Tanosaki R; Tobinai K
Expert Rev Hematol; 2010 Dec; 3(6):743-53. PubMed ID: 21091150
[TBL] [Abstract][Full Text] [Related]
24. Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.
Katsuya H
Int J Hematol; 2023 Apr; 117(4):512-522. PubMed ID: 36862273
[TBL] [Abstract][Full Text] [Related]
25. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
26. Treatment of adult T-cell leukemia.
Uozumi K
J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
[TBL] [Abstract][Full Text] [Related]
28. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients.
Bazarbachi A; Hermine O
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S186-90. PubMed ID: 8797722
[TBL] [Abstract][Full Text] [Related]
29. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
30. Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.
Utsunomiya A
Front Microbiol; 2019; 10():2235. PubMed ID: 31681185
[TBL] [Abstract][Full Text] [Related]
31. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
Ishitsuka K; Tamura K
Lancet Oncol; 2014 Oct; 15(11):e517-26. PubMed ID: 25281470
[TBL] [Abstract][Full Text] [Related]
32. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
Ishitsuka K; Tsukasaki K; Tamura K
Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
[TBL] [Abstract][Full Text] [Related]
33. [Adult T cell leukemia-lymphoma (ATL)].
Tsukasaki K
Nihon Rinsho; 2014 Mar; 72(3):531-7. PubMed ID: 24724415
[TBL] [Abstract][Full Text] [Related]
34. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.
Yamaguchi K; Watanabe T
Int J Hematol; 2002 Aug; 76 Suppl 2():240-5. PubMed ID: 12430931
[TBL] [Abstract][Full Text] [Related]
35. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
[TBL] [Abstract][Full Text] [Related]
36. [Development of future treatment for ATL].
Ishitsuka K
Rinsho Ketsueki; 2021; 62(7):766-773. PubMed ID: 34349061
[TBL] [Abstract][Full Text] [Related]
37.
Hachiman M; Yoshimitsu M; Ezinne C; Kuroki A; Kozako T; Arima N
Oncol Lett; 2018 Jul; 16(1):1305-1311. PubMed ID: 30061950
[TBL] [Abstract][Full Text] [Related]
38. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
39. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
Tsukasaki K; Hermine O; Bazarbachi A; Ratner L; Ramos JC; Harrington W; O'Mahony D; Janik JE; Bittencourt AL; Taylor GP; Yamaguchi K; Utsunomiya A; Tobinai K; Watanabe T
J Clin Oncol; 2009 Jan; 27(3):453-9. PubMed ID: 19064971
[TBL] [Abstract][Full Text] [Related]
40. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.
Winsett FT; Lewis DJ; Duvic M
Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
